CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis Current treatment of significant left main coronary artery disease: A review High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation 1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines The impact of intravascular ultrasound guidance during drug eluting stent implantation on angiographic outcomes Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: insights from the Milan and New-Tokyo (MITO) registry
|<<... 100 101 102 103 104 105 106 ...>>|

Review Article2017 Feb 27;10(4):315-324.

JOURNAL：JACC Cardiovasc Interv. Article Link

Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials

Elgendy IY, Mahmoud AN, Kumbhani DJ et al. Keywords: meta-analysis; myocardial infarction; percutaneous coronary intervention; STEMI; multivessel disease; strategy

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top